ResearcherMoffitt Cancer CenterNo recent work listed
Xiyong Liu
Matched on ORCID iD 0000-0002-0259-3669; OpenAlex author ID A5031124433. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 3
- Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway. Co-author DOI 10.1016/j.pan.2022.03.002↗
- Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach. Co-author DOI 10.1097/mpa.0000000000000710↗
- Effects of the silencing of hypoxia-inducible Factor-1 alpha on metastasis of pancreatic cancer. Last author PMID 23467940↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jinlan Shan · 1 shared paper, 2022 · strength 0.16
- Tao Zhang · 1 shared paper, 2022 · strength 0.16
- Xiaochen Wang · 1 shared paper, 2022 · strength 0.16
- Zhen Wang · 1 shared paper, 2022 · strength 0.16
- F Li · 1 shared paper, 2013 · strength 0.05
- Peng Fu · 1 shared paper, 2013 · strength 0.05
- Haiyan Wei · 1 shared paper, 2013 · strength 0.05
- Chandan Guha · 1 shared paper, 2016 · strength 0.05
- William F. Regine · 1 shared paper, 2016 · strength 0.05
- John S. Macdonald · 1 shared paper, 2016 · strength 0.05
- Yun Yen · 1 shared paper, 2016 · strength 0.05
- Hany Elsaleh · 1 shared paper, 2016 · strength 0.05
- James J. Farrell · 1 shared paper, 2016 · strength 0.05
- Al B. Benson · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.